Celebrating Excellence: Accolades for Dr. Jacob Jesurun, Dr. Swetha, and Teams in Pharmacology and Clinical Pharmacy
Title:
link to the file: https://www.ipc.gov.in/images/Top_10_AMCs_Felicitation_without_PvA_1_1.pdfWe are thrilled to announce and extend heartfelt congratulations to Dr. Jacob Jesurun, Dr. Swetha, and the entire dedicated teams in Pharmacology and Clinical Pharmacy for achieving a remarkable milestone. Our institution has been prominently featured in the esteemed newsletter of the Indian Pharmacopoeia Commission, Ministry of Health and Human Welfare, Government of India, as the TOP PERFORMING ADR MONITORING CENTRE.
Acknowledging Excellence in Adverse Drug Reaction (ADR) Monitoring:
This recognition is a testament to the unwavering commitment, expertise, and diligence exhibited by Dr. Jacob Jesurun, Dr. Swetha, and their teams in the field of Pharmacology and Clinical Pharmacy. The distinction of being recognized as a top-performing center in ADR monitoring is a reflection of the high standards of care and precision maintained in our institution.
Pioneering Efforts in Patient Safety:
The field of pharmacovigilance and adverse drug reaction monitoring plays a pivotal role in ensuring patient safety and the effectiveness of medical interventions. Dr. Jacob Jesurun, Dr. Swetha, and their teams have not only demonstrated excellence in their day-to-day responsibilities but have also contributed significantly to the broader landscape of healthcare quality and safety.
Collaborative Success:
This achievement is a result of collaborative efforts, highlighting the importance of teamwork and interdisciplinary collaboration within our institution. The dedication and expertise demonstrated by each member of the Pharmacology and Clinical Pharmacy teams have set a standard of excellence that reflects positively on our institution as a whole.
Impacting Healthcare on a National Level:
Being featured in the newsletter of the Indian Pharmacopoeia Commission places our institution at the forefront of advancements in pharmacovigilance at a national level. This recognition not only reflects the commitment of our teams but also reinforces our institution's role in shaping the future of healthcare in India.
A Bright Future Ahead:
As we celebrate this achievement, we look forward to building on this success and continuing to set new benchmarks in patient safety, pharmacovigilance, and clinical pharmacy. Dr. Jacob Jesurun, Dr. Swetha, and all team members have showcased the exceptional capabilities and dedication that define our institution.
In Conclusion:
This accomplishment is a source of pride for everyone associated with our institution. It is a testament to our commitment to excellence, patient safety, and the advancement of healthcare standards. We extend our warmest congratulations once again to Dr. Jacob Jesurun, Dr. Swetha, and all the teams involved for this well-deserved recognition.
In celebration of excellence and looking forward to continued success,
https://www.ipc.gov.in/news-highlights/1195-3rd-national-pharmacovigilance-week.html
Comments
Post a Comment